Enlivex Therapeutics

Recent Finacing

Post-IPO Equity

Recent Raise

$212M

Enlivex Therapeutics is an Israel-based, clinical-stage biotechnology company developing Allocetra, a macrophage-based therapy for osteoarthritis, while pursuing an unconventional blockchain-token treasury strategy.

HaMerkaz, Israel

11-50

Publicly Traded

enlivex.com